Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma 19Fibrosarcoma 8Leiomyosarcoma 7Sarcoma, Synovial 6Rhabdomyosarcoma 6Neurofibrosarcoma 6Lymphoma 6Liposarcoma 6Histiocytoma, Malignant Fibrous 6Hemangiosarcoma 6Osteosarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Malignant mesenchymal tumor 5Hemangiopericytoma, Malignant 5Burkitt Lymphoma 4Testicular Neoplasms 3Teratoma 3Sarcoma, Ewing 3Sarcoma, Alveolar Soft Part 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Carcinoma, Embryonal 3Wilms Tumor 2Sarcoma, Endometrial Stromal 2Pheochromocytoma 2Neuroblastoma 2Neoplasm Metastasis 2Leukemia 2

Interventions

Radiosurgery 1Pemetrexed 1Palliative Care 1Nutritional Support 1Ifosfamide 1Glutamine 1Celecoxib 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Chondrosarcoma × Ifosfamide × Clear all
NCT00003292 2013-11-08

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

SWOG Cancer Research Network

Phase 2 Terminated
7 enrolled
CNSSarcoma

Chondrosarcoma, Fibrosarcoma, Leiomyosarcoma, Meningioma, Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡